{"id":"https://openalex.org/W2140136732","doi":"https://doi.org/10.1016/j.bmcl.2009.08.091","title":"Discovery of 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051-a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia","display_name":"Discovery of 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051-a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia","publication_year":2009,"publication_date":"2009-09-03","ids":{"openalex":"https://openalex.org/W2140136732","doi":"https://doi.org/10.1016/j.bmcl.2009.08.091","mag":"2140136732","pmid":"https://pubmed.ncbi.nlm.nih.gov/19783139"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2009.08.091","doi":"https://doi.org/10.1016/j.bmcl.2009.08.091","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2009.08.091","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Takahiro Sato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266857","display_name":"Fuji Yakuhin Co., Ltd. (Japan)","ror":"https://ror.org/0031t6k06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405266857"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Takahiro Sato","raw_affiliation_strings":["Research Laboratories 1, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 3936-2 Sashiougi, Nishi-ku, Saitama-shi, Saitama 331-0047, Japan. takahiro@fujiyakuhin.co.jp","Research Laboratories 1, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 3936-2 Sashiougi, Nishi-ku, Saitama-shi, Saitama 331-0047, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories 1, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 3936-2 Sashiougi, Nishi-ku, Saitama-shi, Saitama 331-0047, Japan. takahiro@fujiyakuhin.co.jp","institution_ids":["https://openalex.org/I4405266857"]},{"raw_affiliation_string":"Research Laboratories 1, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 3936-2 Sashiougi, Nishi-ku, Saitama-shi, Saitama 331-0047, Japan","institution_ids":["https://openalex.org/I4405266857"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052010897","display_name":"Naoki Ashizawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266857","display_name":"Fuji Yakuhin Co., Ltd. (Japan)","ror":"https://ror.org/0031t6k06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405266857"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoki Ashizawa","raw_affiliation_strings":["Research Laboratories 2, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 636-1 Iidashinden, Nishi-ku, Saitama-shi, Saitama 331-0068, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories 2, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 636-1 Iidashinden, Nishi-ku, Saitama-shi, Saitama 331-0068, Japan","institution_ids":["https://openalex.org/I4405266857"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089906631","display_name":"Koji Matsumoto","orcid":"https://orcid.org/0000-0003-4319-1970","observed_orcids":["https://orcid.org/0000-0003-4319-1970"]},"institutions":[{"id":"https://openalex.org/I4405266857","display_name":"Fuji Yakuhin Co., Ltd. (Japan)","ror":"https://ror.org/0031t6k06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405266857"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koji Matsumoto","raw_affiliation_strings":["Research Laboratories 2, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 636-1 Iidashinden, Nishi-ku, Saitama-shi, Saitama 331-0068, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories 2, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 636-1 Iidashinden, Nishi-ku, Saitama-shi, Saitama 331-0068, Japan","institution_ids":["https://openalex.org/I4405266857"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Takashi Iwanaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266857","display_name":"Fuji Yakuhin Co., Ltd. (Japan)","ror":"https://ror.org/0031t6k06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405266857"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Iwanaga","raw_affiliation_strings":["Research Laboratories 2, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 636-1 Iidashinden, Nishi-ku, Saitama-shi, Saitama 331-0068, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories 2, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 636-1 Iidashinden, Nishi-ku, Saitama-shi, Saitama 331-0068, Japan","institution_ids":["https://openalex.org/I4405266857"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102019175","display_name":"Hiroshi Nakamura","orcid":"https://orcid.org/0000-0001-7699-9840","observed_orcids":["https://orcid.org/0000-0001-7699-9840"]},"institutions":[{"id":"https://openalex.org/I61575859","display_name":"Josai International University","ror":"https://ror.org/039pch476","country_code":"JP","type":"education","lineage":["https://openalex.org/I61575859"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Nakamura","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Josai International University, 1 Gumyo, Togane-shi, Chiba 283-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Josai International University, 1 Gumyo, Togane-shi, Chiba 283-8555, Japan","institution_ids":["https://openalex.org/I61575859"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078649762","display_name":"Tsutomu Inoue","orcid":"https://orcid.org/0000-0003-2349-3322","observed_orcids":["https://orcid.org/0000-0003-2349-3322"]},"institutions":[{"id":"https://openalex.org/I4405266857","display_name":"Fuji Yakuhin Co., Ltd. (Japan)","ror":"https://ror.org/0031t6k06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405266857"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsutomu Inoue","raw_affiliation_strings":["Research Laboratories 1, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 3936-2 Sashiougi, Nishi-ku, Saitama-shi, Saitama 331-0047, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories 1, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 3936-2 Sashiougi, Nishi-ku, Saitama-shi, Saitama 331-0047, Japan","institution_ids":["https://openalex.org/I4405266857"]}]},{"author_position":"last","author":{"id":null,"display_name":"Osamu Nagata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266857","display_name":"Fuji Yakuhin Co., Ltd. (Japan)","ror":"https://ror.org/0031t6k06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405266857"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Osamu Nagata","raw_affiliation_strings":["Research Laboratories 2, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 636-1 Iidashinden, Nishi-ku, Saitama-shi, Saitama 331-0068, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories 2, Research Department, Medical R&D Division, Fuji Yakuhin Co., Ltd, 636-1 Iidashinden, Nishi-ku, Saitama-shi, Saitama 331-0068, Japan","institution_ids":["https://openalex.org/I4405266857"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405266857"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":2.0296,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.87712706,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"19","issue":"21","first_page":"6225","last_page":"6229"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.014399999752640724,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/xanthine-oxidoreductase-inhibitors","display_name":"xanthine oxidoreductase inhibitors","score":0.925000011920929},{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/serum-uric-acid-lowering","display_name":"serum uric acid lowering","score":0.8659999966621399},{"id":"https://openalex.org/keywords/cyp3a4-inhibition","display_name":"CYP3A4 inhibition","score":0.9509999752044678},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9319999814033508},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.5590000152587891},{"id":"https://openalex.org/keywords/urate-lowering-therapy","display_name":"urate-lowering therapy","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8978861570358276},{"id":"https://openalex.org/C2779721657","wikidata":"https://www.wikidata.org/wiki/Q49970","display_name":"Hyperuricemia","level":3,"score":0.7366674542427063},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6436867713928223},{"id":"https://openalex.org/C2779953769","wikidata":"https://www.wikidata.org/wiki/Q412567","display_name":"Benzonitrile","level":2,"score":0.6296120285987854},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.6268209218978882},{"id":"https://openalex.org/C2777907353","wikidata":"https://www.wikidata.org/wiki/Q903341","display_name":"Triazole","level":2,"score":0.5711929798126221},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4945504367351532},{"id":"https://openalex.org/C2781002465","wikidata":"https://www.wikidata.org/wiki/Q161297","display_name":"1,2,3-Triazole","level":2,"score":0.48932522535324097},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.47380131483078003},{"id":"https://openalex.org/C2779470414","wikidata":"https://www.wikidata.org/wiki/Q50980","display_name":"Xanthine","level":3,"score":0.4164985418319702},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.3350732922554016},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2742593288421631},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.15577474236488342},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.13947850465774536},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.12175190448760986},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.07961183786392212},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014968","descriptor_name":"Xanthine Dehydrogenase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014968","descriptor_name":"Xanthine Dehydrogenase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D033461","descriptor_name":"Hyperuricemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D065692","descriptor_name":"Cytochrome P-450 CYP3A Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2009.08.091","doi":"https://doi.org/10.1016/j.bmcl.2009.08.091","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2009.08.091","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:19783139","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19783139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1984326321","https://openalex.org/W2042464158","https://openalex.org/W2047276432","https://openalex.org/W2047721165","https://openalex.org/W2052925570","https://openalex.org/W2076565275","https://openalex.org/W2085812181","https://openalex.org/W2087831705","https://openalex.org/W2098144815","https://openalex.org/W2126654035","https://openalex.org/W3134263331"],"related_works":["https://openalex.org/W2952128802","https://openalex.org/W4297177514","https://openalex.org/W2085812181","https://openalex.org/W4207052121","https://openalex.org/W2114104370","https://openalex.org/W2963392551","https://openalex.org/W2745975919","https://openalex.org/W3037378112","https://openalex.org/W1969856573","https://openalex.org/W4402786738"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}